×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Skip to main content
Tags: hydroxychloroquine | chloroquine | study | arrhythmia

Study Finds Hydroxychloroquine Linked to Increased Death Rates

doctor in a white lab coat holds two packets of white round tablets
Medical staff shows packets of tablets containing chloroquine and hydroxychloroquine, drugs that were thought to show signs of effectiveness against coronavirus. (Gerard Julien/Getty Images)

By    |   Friday, 22 May 2020 09:42 AM EDT

An analysis of 96,000 hospitalized coronavirus patients on six continents reveals those who received the antimalarial drug touted by President Donald Trump had a higher risk of death compared with those who did not take it.

The study was published Friday in the medical journal The Lancet and detailed in a report by The Washington Post. It found that those treated with hydroxychloroquine, or the closely related drug chloroquine, were more likely to develop an irregular heart rhythm that could lead to sudden cardiac death.

The Post noted the study is the largest analysis of the risk and benefits of treating those infected with the coronavirus with antimalarial drugs. The findings were based on an analysis of medical records and not a controlled study.

The new analysis was led by Mandeep Mehra, a Harvard Medical School professor, and colleagues at other institutions.

According to the Post, there was a 34% increase in the risk of mortality and a 137% increase in the risk of serious heart arrhythmias for those given hydroxychloroquine. And for those who received hydroxychloroquine and an antibiotic, there was a 45% increased risk of death and a 411% increased risk of serious heart arrhythmias.

David Maron, director of preventive cardiology at the Stanford University School of Medicine, said that “these findings provide absolutely no reason for optimism that these drugs might be useful in the prevention or treatment of COVID-19."

Trump on Tuesday had defended his use of hydroxychloroquine telling reporters it “gives you an additional level of safety."

© 2022 Newsmax. All rights reserved.


US
An analysis of 96,000 hospitalized coronavirus patients on six continents reveals those who received the antimalarial drug touted by President Donald Trump had a higher risk of death compared with those who did not take it. The study was published Friday in the medical...
hydroxychloroquine, chloroquine, study, arrhythmia
253
2020-42-22
Friday, 22 May 2020 09:42 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved